Skip to main content

Table 4 Incidence of prostate cancer upstaging regarding T stage after mpMRI

From: Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience

cT1–2 Tumors n Tumor upstaging (n) Percentage of tumor upstaging
Gleason score < 7 42 19 45.2%
Gleason score 7 40 24 60%
Gleason score > 7 15 8 53%
PSA level < 10 ng/ml 44 22 50%
PSA level 10–20 ng/ml 30 16 53.3%
PSA level > 20 ng/ml 23 17 73.9%
  1. Incidence of prostate cancer upstaging regarding T stage after mpMRI depending on initial serum PSA level and the Gleason score in patients initially staged as cT1–cT2 (n = 97).
\